ArticleFrontiers in medicine2025
Assessment of bone health in pre-dialysis CKD patients based on TBS reference range for the Chinese population.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pre-dialysis chronic kidney disease (CKD) Patients show a markedly elevated risk of fractures, and BMD assessments offer only limited insights into their bone health. The trabecular bone score (TBS), a newly introduced parameter for evaluating bone microarchitecture, is recommended for studying bone health under this context. Methods: A total of 46 subjects were included in the control group, and 136 patients were included in the CKD group. All participants underwent laboratory examinations, Dual energy X-ray absorptiometry (DXA) scans, and medical history reviews. The relationships between TBS and demographic characteristics, history of fractures, LS-BMD, FN-BMD, and laboratory parameters were analyzed. Results: Age, gender, and BMI were matched between the control and CKD groups (P > 0.05). The control group had an average age of 64.96 ± 7.76 years with 27 females (58.70%), while the CKD group had an average age of 64.42 ± 10.90 years with 66 females (48.53%). Among the CKD group, 43 patients had fractures. In both control and CKD participants, when BMD was normal or osteopenia, TBS frequently indicated partially reduced bone microarchitecture or reduced bone microarchitecture, a statistically significant finding ( Conclusion: In pre-dialysis CKD patients with normal or reduced BMD, TBS is significantly associated with fracture risk. Additional evaluation of bone microstructure using TBS enhances fracture risk identification, particularly in patients with relatively high BMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.